Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -40.25%355.06K | -35.54%400.44K | 10.67%576.78K | 135.29%2.24M | 16.93%504.93K | 107.38%594.28K | 181.03%621.24K | 3,829.65%521.19K | 952.69K | 431.81K |
| Operating revenue | -40.25%355.06K | -35.54%400.44K | 10.67%576.78K | 135.29%2.24M | 16.93%504.93K | 107.38%594.28K | 181.03%621.24K | 3,829.65%521.19K | --952.69K | --431.81K |
| Cost of revenue | -28.65%125.94K | 27.59%206.63K | 1.50%242.82K | 244.52%998.07K | 4,973.37%418.82K | 16.54%176.5K | 22.57%161.94K | 1,713.56%239.25K | 8,522.08%289.7K | -1,077.70%-8.59K |
| Gross profit | -45.16%229.12K | -57.80%193.81K | 18.45%333.95K | 87.57%1.24M | -80.45%86.11K | 209.22%417.77K | 416.43%459.3K | 397,004.23%281.94K | 19,831.85%662.99K | 50,202.28%440.4K |
| Operating expense | -25.99%125.73K | 115.53%311.26K | -18.77%168.33K | 29.54%643.45K | -29.63%123.63K | 39.53%169.87K | 65.46%144.41K | 82.53%207.23K | -59.85%496.72K | -61.89%175.69K |
| Selling and administrative expenses | -24.94%61.83K | 185.55%139.74K | -3.44%77.29K | 40.92%301.59K | -5.77%90.24K | 51.11%82.37K | 193.91%48.94K | 69.96%80.05K | -60.96%214.01K | -71.85%95.76K |
| -General and administrative expense | -24.94%61.83K | 185.55%139.74K | -3.44%77.29K | 40.92%301.59K | -5.77%90.24K | 51.11%82.37K | 193.91%48.94K | 69.96%80.05K | -60.96%214.01K | -71.85%95.76K |
| Research and development costs | -90.73%1.98K | -78.81%6.68K | -69.14%20.73K | 198.12%131.39K | -50.61%11.41K | 106.58%21.29K | 515.69%31.52K | 1,111.62%67.17K | -81.13%44.07K | -73.96%23.1K |
| Depreciation amortization depletion | ---- | ---- | -78.62%334 | ---- | ---- | ---- | ---- | 2.70%1.56K | ---- | ---- |
| -Depreciation and amortization | ---- | ---- | -78.62%334 | ---- | ---- | ---- | ---- | 2.70%1.56K | ---- | ---- |
| Other taxes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Other operating expenses | -6.46%61.93K | 157.72%164.84K | 19.72%69.98K | -11.80%210.47K | -61.32%21.98K | 16.30%66.21K | -2.36%63.96K | -1.55%58.45K | -47.31%238.64K | 91.06%56.83K |
| Operating profit | -58.30%103.39K | -137.30%-117.45K | 121.67%165.62K | 260.94%600.12K | -114.17%-37.52K | 1,755.79%247.9K | 18,868.98%314.89K | 165.85%74.72K | 113.40%166.27K | 157.30%264.71K |
| Net non-operating interest income (expenses) | -61.83%-28.48K | -48.72%-45.16K | -20.32%-35.82K | 24.22%-104.3K | 70.28%-26.43K | 13.31%-17.6K | -60.36%-30.37K | -213.98%-29.77K | -7,589.39%-137.64K | -6,934.89%-88.92K |
| Non-operating interest income | --0 | --0 | --0 | 477.98%7.51K | 42.42%1.85K | --1.89K | --1.89K | --1.87K | --1.3K | --1.3K |
| Non-operating interest expense | 47.51%28.11K | -11.75%27.88K | 12.63%35.48K | -19.83%110.22K | -68.67%28.08K | -5.17%19.06K | 67.85%31.59K | 251.10%31.5K | 44,683.39%137.49K | --89.61K |
| Total other finance cost | -14.29%372 | 2,494.89%17.28K | 135.17%341 | 9.28%1.59K | -66.78%204 | 108.65%434 | 479.13%666 | -71.57%145 | -1.96%1.45K | -35.84%614 |
| Other net income (expenses) | -10.57K | 80.97%-58.73K | 79.98%-58.05K | -50.53%-308.63K | -325.65%-290K | |||||
| Gain on sale of security | ---10.57K | ---- | ---- | -215.26%-58.73K | ---- | ---- | ---- | ---- | 92.51%-18.63K | --0 |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---290K | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --290K | ---- |
| Income before tax | -72.06%64.34K | -157.15%-162.61K | 188.81%129.8K | 256.10%437.08K | -7.41%-122.68K | 3,416.50%230.3K | 1,747.00%284.52K | 131.75%44.94K | 80.65%-280K | 65.87%-114.22K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -72.06%64.34K | -157.15%-162.61K | 188.81%129.8K | 256.10%437.08K | -7.41%-122.68K | 3,416.50%230.3K | 1,747.00%284.52K | 131.75%44.94K | 80.65%-280K | 65.87%-114.22K |
| Net income continuous operations | -72.06%64.34K | -157.15%-162.61K | 188.81%129.8K | 256.10%437.08K | -7.41%-122.68K | 3,416.50%230.3K | 1,747.00%284.52K | 131.75%44.94K | 80.65%-280K | 65.87%-114.22K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -72.06%64.34K | -157.15%-162.61K | 188.80%129.8K | 256.10%437.08K | -7.41%-122.68K | 3,416.50%230.3K | 1,747.09%284.52K | 131.75%44.94K | 80.61%-280K | 65.47%-114.22K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -72.06%64.34K | -157.15%-162.61K | 188.80%129.8K | 256.10%437.08K | -7.41%-122.68K | 3,416.50%230.3K | 1,747.09%284.52K | 131.75%44.94K | 80.61%-280K | 65.47%-114.22K |
| Diluted earnings per share | 0 | 0 | 0 | 0.01 | -171.96%-0.0017 | 0 | 0 | 0 | 0 | 0.0023 |
| Basic earnings per share | 0 | 0 | 0 | 0.01 | -171.96%-0.0017 | 0 | 0 | 0 | 0 | 223.30%0.0023 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.